On combination therapy of diabetes with metformin and dipeptidyl peptidase IV inhibitors

被引：12
|
作者：
Hinke, SA
McIntosh, CHS
Hoffmann, T
Kuhn-Wache, K
Wagner, L
Bär, J
Manhart, S
Wermann, M
Pederson, RA
Demuth, HU
机构：
[1] Probiodrug AG, D-06120 Halle Saale, Germany
[2] Univ British Columbia, Dept Physiol, Vancouver, BC V5Z 1M9, Canada
来源：
DIABETES CARE | 2002年 / 25卷 / 08期
关键词：
D O I：
10.2337/diacare.25.8.1490-b
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1490 / 1491
页数：2
相关论文
共 50 条
  • [41] Which patients are candidates for dipeptidyl peptidase IV inhibitors?
    Marrs, Joel C.
    Saseen, Joseph J.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2007, 64 (12) : 1261 - 1261
  • [42] Effects of combination therapy with dipeptidyl peptidase-IV and histone deacetylase inhibitors in the non-obese diabetic mouse model of type 1 diabetes
    Cabrera, S. M.
    Colvin, S. C.
    Tersey, S. A.
    Maier, B.
    Nadler, J. L.
    Mirmira, R. G.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2013, 172 (03): : 375 - 382
  • [43] DIPEPTIDE PHOSPHONATES AS INHIBITORS OF DIPEPTIDYL PEPTIDASE-IV
    BODUSZEK, B
    OLEKSYSZYN, J
    KAM, CM
    SELZLER, J
    SMITH, RE
    POWERS, JC
    JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (23) : 3969 - 3976
  • [44] Angioedema associated with dipeptidyl peptidase-IV inhibitors
    Cassano N.
    Nettis E.
    Di Leo E.
    Ambrogio F.
    Vena G.A.
    Foti C.
    Clinical and Molecular Allergy, 19 (1)
  • [45] Diprolyl nitriles as potent dipeptidyl peptidase IV inhibitors
    Zhao, GH
    Taunk, PC
    Magnin, DR
    Simpkins, LM
    Robl, JA
    Wang, AY
    Robertson, JG
    Marcinkeviciene, J
    Sitkoff, DF
    Parker, RA
    Kirby, MS
    Hamann, LG
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (18) : 3992 - 3995
  • [46] Potent inhibitors of dipeptidyl peptidase IV and their mechanisms of inhibition
    Stöckel-Maschek, A
    Stiebitz, B
    Born, I
    Faust, J
    Mögelin, W
    Neubert, K
    CELLULAR PEPTIDASES IN IMMUNE FUNCTIONS AND DISEASES 2, 2000, 477 : 117 - 123
  • [47] Xanthine mimetics as potent dipeptidyl peptidase IV inhibitors
    Kurukulasuriya, Ravi
    Rohde, Jeffrey J.
    Szczepankiewicz, Bruce G.
    Basha, Fatima
    Lai, Chunqui
    Jae, Hwan-Soo
    Winn, Martin
    Stewart, Kent D.
    Longenecker, Kenton L.
    Lubben, Thomas W.
    Ballaron, Stephen J.
    Sham, Hing L.
    von Geldern, Thomas W.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (24) : 6226 - 6230
  • [48] Ketopyrrolidines and ketoazetidines as potent dipeptidyl peptidase IV (DPP IV) inhibitors
    Ferraris, D
    Ko, YS
    Calvin, D
    Chiou, T
    Lautar, S
    Thomas, B
    Wozniak, K
    Rojas, C
    Kalish, V
    Belyakov, S
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (22) : 5579 - 5583
  • [49] Optimizing the treatment of newly diagnosed type 2 diabetes mellitus with combination of dipeptidyl peptidase-4 inhibitors and metformin: An expert opinion
    Das, Ashok K.
    Gandhi, Pramod
    Saboo, Banshi
    Reddy, Sanjay
    Chawla, Rajeev
    Zargar, Abdul Hamid
    Kovil, Rajiv
    Chawla, Manoj
    Sharma, S. K.
    Gupta, Sunil
    Makkar, B. M.
    Mittal, Vinod
    Goswami, Soumik
    Arvind, S. R.
    Jaggi, Shalini
    Bajaj, Sarita
    Das, Sambit
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2021, 10 (12) : 4398 - 4409
  • [50] Azetidine-based inhibitors of dipeptidyl peptidase IV (DPP IV)
    Ferraris, Dana
    Belyakov, Sergei
    Li, Weixing
    Oliver, Eddie
    Ko, Yao-Sen
    Calvin, David
    Lautar, Susan
    Thomas, Bert
    Rojas, Camilo
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2007, 7 (06) : 597 - 608
12345